Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
19
Frequently Asked Questions
What is Market Cap of Agile Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Agile Therapeutics Inc market cap is $2.74M.
What is the 52-week high for Agile Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Agile Therapeutics Inc 52 week high is $6.71 as of September 09, 2025.
What is the 52-week low for Agile Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Agile Therapeutics Inc 52 week low is $0.20 as of September 09, 2025.
What is Agile Therapeutics Inc stock price today?
Agile Therapeutics Inc stock price today is $0.4297.
What was Agile Therapeutics Inc stock price yesterday?
Agile Therapeutics Inc stock price yesterday was $0.40.
What is the PE ratio of Agile Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Agile Therapeutics Inc’s P/E ratio is -0.04.
What is the Price-to-Book ratio of Agile Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Agile Therapeutics Inc P/B ratio is -0.0726.
What is Agile Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Agile Therapeutics Inc's EBITDA is -0.28.
What is the 50-day moving average of Agile Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Agile Therapeutics Inc 50-day moving average is $0.5831.
How many employess does Agile Therapeutics Inc has?
